UBS US Dividend Ruler P (DVRUX)
11.83
-0.04 (-0.34%)
USD |
Jun 30 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.50% | 119.33M | 1.39% | 24.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 52.37M | -5.01% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to maximize total return, consisting of capital appreciation and current income. Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes, if any) in U.S. companies. In addition, under normal circumstances, it invests at least 80% of its net assets (plus borrowings for investment purposes, if any) in dividend paying securities. The fund also may at times invest in ETFs and other investment companies for the purpose of gaining exposure to the stock market while maintaining liquidity. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | DVRUX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | UBS Asset Management |
| Prospectus Benchmark Index | |
| N/A | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Christopher Shea | 1.90 yrs |
| Edmund Tran | 1.90 yrs |
| Jeffrey Hans | 1.90 yrs |
| Jeremy Zirin | 1.90 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
22
52.37M
-5.417B
Category Low
19.57B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 30, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 30, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 8.40% | 259.51 | 1.04% |
| Johnson & Johnson | 3.81% | 179.55 | 1.15% |
| Raytheon Technologies Corp | 3.77% | 97.03 | 0.96% |
| Coca-Cola Co | 3.52% | 64.42 | 2.40% |
| Analog Devices Inc | 3.23% | 143.01 | -2.11% |
| Linde PLC | 3.09% | 285.37 | -0.75% |
| UnitedHealth Group Inc | 3.08% | 517.33 | 0.72% |
| Chubb Ltd | 3.06% | 198.03 | 0.74% |
| Medtronic PLC | 3.05% | 91.33 | 1.76% |
| Cisco Systems Inc | 3.05% | 42.63 | -0.02% |
Basic Info
| Investment Strategy | |
| The investment seeks to maximize total return, consisting of capital appreciation and current income. Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes, if any) in U.S. companies. In addition, under normal circumstances, it invests at least 80% of its net assets (plus borrowings for investment purposes, if any) in dividend paying securities. The fund also may at times invest in ETFs and other investment companies for the purpose of gaining exposure to the stock market while maintaining liquidity. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | DVRUX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | UBS Asset Management |
| Prospectus Benchmark Index | |
| N/A | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Christopher Shea | 1.90 yrs |
| Edmund Tran | 1.90 yrs |
| Jeffrey Hans | 1.90 yrs |
| Jeremy Zirin | 1.90 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-30-22) | 1.39% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 21.39 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 7/9/2020 |
| Last Annual Report Date | 7/30/2021 |
| Last Prospectus Date | 10/28/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |